| Line Item | 2025-05-25 | Y/Y |
|---|---|---|
| Revenue | $6.45B | -0.3% |
| Cost of Revenue | $5.05B | +7.5% |
| Gross Profit | $1.40B | -20.8% |
| R&D Expense | $22.0M | -16.7% |
| SG&A Expense | $633.5M | -9.7% |
| Operating Income | $665.1M | -37.6% |
| Pre-tax Income | $500.3M | -47.6% |
| Income Tax | $143.1M | -37.8% |
| Net Income | $357.2M |
| Line Item | 2025-05-25 | Y/Y |
|---|---|---|
| Cash & Equivalents | $70.7M | -1.0% |
| Accounts Receivable | $781.6M | +5.1% |
| Inventory | $1.04B | -9.1% |
| Current Assets | $2.03B | -2.7% |
| Total Assets | $7.39B | +0.3% |
| Current Liabilities | $1.48B | -9.1% |
| Long-term Debt | $3.77B | -1.7% |
| Line Item | 2025-05-25 | Y/Y |
|---|---|---|
| Operating Cash Flow | $868.3M | +8.8% |
| Capital Expenditures | $638.2M | -31.3% |
| Investing Cash Flow | -$648.0M | +34.2% |
| Financing Cash Flow | -$225.0M | -368.8% |
| Free Cash Flow | $230.1M | +275.2% |
| -50.8% |
| EPS (Basic) | $2.51 | -49.9% |
| EPS (Diluted) | $2.50 | -49.8% |
| Stockholders' Equity |
| $1.74B |
| -2.8% |